Maria Cancio
Overview
Explore the profile of Maria Cancio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
1028
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kernan N, Klein E, Mauguen A, Torok-Castanza J, Prockop S, Scaradavou A, et al.
Transplant Cell Ther
. 2024 Apr;
30(7):692.e1-692.e12.
PMID: 38643958
The clinical value of serial routine bone marrow aspirates (rBMAs) in the first year after allogeneic hematopoietic cell transplantation (alloHCT) to detect or predict relapse of acute leukemia (AL) and...
2.
Major-Monfried H, Hosszu K, McAvoy D, Vallone A, Shukla N, Gillio A, et al.
Cytotherapy
. 2024 Mar;
26(5):466-471.
PMID: 38430078
Background Aims: Daratumumab, a human IgG monoclonal antibody targeting CD38, is a promising treatment for pediatric patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL). We describe a case...
3.
Pickett L, Daukshus N, Camacho-Bydume C, Mathew S, Mauguen A, Cohen N, et al.
Pediatr Infect Dis J
. 2024 Jan;
43(5):457-462.
PMID: 38190640
Background: Cytomegalovirus (CMV) infection following allogeneic hematopoietic cell transplantation has considerable morbidity and mortality, and foscarnet is a treatment option that requires renal dose adjustment. Serum creatinine (SCr)-based estimated glomerular...
4.
Cancio M, Troullioud Lucas A, Bierings M, Klein E, de Witte M, Smiers F, et al.
Bone Marrow Transplant
. 2023 Oct;
59(1):34-40.
PMID: 37848556
Allogeneic hematopoietic cell transplantation (HCT) remains the only cure for the hematologic manifestations of Fanconi anemia (FA). We performed retrospective predictor analyses for HCT outcomes in FA for pediatric and...
5.
Satty A, Klein E, Mauguen A, Kunvarjee B, Boelens J, Cancio M, et al.
Bone Marrow Transplant
. 2023 Sep;
59(1):23-33.
PMID: 37773270
The only curative approach for myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) arising in patients with Fanconi anemia (FA) is allogeneic hematopoietic stem cell transplantation (HCT); however, HCT approaches...
6.
Sharma A, Boelens J, Cancio M, Hankins J, Bhad P, Azizy M, et al.
N Engl J Med
. 2023 Aug;
389(9):820-832.
PMID: 37646679
Background: Sickle cell disease is caused by a defect in the β-globin subunit of adult hemoglobin. Sickle hemoglobin polymerizes under hypoxic conditions, producing deformed red cells that hemolyze and cause...
7.
Kunvarjee B, Bidgoli A, Madan R, Vidal E, McAvoy D, Hosszu K, et al.
J Allergy Clin Immunol
. 2023 Jun;
152(3):815-817.
PMID: 37367708
No abstract available.
8.
Webster A, Sanders M, Patel K, Dietrich R, Noonan R, Lach F, et al.
Nature
. 2022 Nov;
612(7940):495-502.
PMID: 36450981
Fanconi anaemia (FA), a model syndrome of genome instability, is caused by a deficiency in DNA interstrand crosslink repair resulting in chromosome breakage. The FA repair pathway protects against endogenous...
9.
Fraint E, Farooki S, Klein E, Mauguen A, Prockop S, Scaradavou A, et al.
Transplant Cell Ther
. 2022 Oct;
29(1):46.e1-46.e6.
PMID: 36210027
Poor graft function (PGF) is a life-threatening complication after allogeneic stem cell transplantation (alloSCT). Historically, outcomes of patients with PGF have been very poor, and there are no standardized approaches...
10.
Zinter M, Versluys A, Lindemans C, Mayday M, Reyes G, Sunshine S, et al.
Sci Transl Med
. 2022 Mar;
14(635):eabm8646.
PMID: 35263147
Impaired baseline lung function is associated with mortality after pediatric allogeneic hematopoietic cell transplantation (HCT), yet limited knowledge of the molecular pathways that characterize pretransplant lung function has hindered the...